Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis

BACKGROUND: Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD). We herein compare health outcomes associated with carvedilol or bisoprolol use, the most commonly prescribed BBs in these patients. METH...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Kidney J
Autori principali: Wu, Ping-Hsun, Lin, Yi-Ting, Liu, Jia-Sin, Tsai, Yi-Chun, Kuo, Mei-Chuan, Chiu, Yi-Wen, Hwang, Shang-Jyh, Carrero, Juan-Jesus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2021
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986334/
https://ncbi.nlm.nih.gov/pubmed/33779636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa248
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi